177 related articles for article (PubMed ID: 33807462)
1. Increased HERV-K(HML-2) Transcript Levels Correlate with Clinical Parameters of Liver Damage in Hepatitis C Patients.
Weber M; Padmanabhan Nair V; Bauer T; Sprinzl MF; Protzer U; Vincendeau M
Cells; 2021 Mar; 10(4):. PubMed ID: 33807462
[TBL] [Abstract][Full Text] [Related]
2. Chronic HCV Infection Is Associated with Overexpression of Human Endogenous Retroviruses that Persists after Drug-Induced Viral Clearance.
Tovo PA; Garazzino S; Daprà V; Alliaudi C; Silvestro E; Calvi C; Montanari P; Galliano I; Bergallo M
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32492928
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 Infection of Primary CD4
Young GR; Terry SN; Manganaro L; Cuesta-Dominguez A; Deikus G; Bernal-Rubio D; Campisi L; Fernandez-Sesma A; Sebra R; Simon V; Mulder LCF
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046457
[TBL] [Abstract][Full Text] [Related]
4. Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals.
Contreras-Galindo R; Kaplan MH; Markovitz DM; Lorenzo E; Yamamura Y
AIDS Res Hum Retroviruses; 2006 Oct; 22(10):979-84. PubMed ID: 17067267
[TBL] [Abstract][Full Text] [Related]
5. Human Endogenous Retroviruses-K (HML-2) Expression Is Correlated with Prognosis and Progress of Hepatocellular Carcinoma.
Ma W; Hong Z; Liu H; Chen X; Ding L; Liu Z; Zhou F; Yuan Y
Biomed Res Int; 2016; 2016():8201642. PubMed ID: 28070518
[No Abstract] [Full Text] [Related]
6. Human endogenous retrovirus HERV-K(HML-2) Rec expression and transcriptional activities in normal and rheumatoid arthritis synovia.
Ehlhardt S; Seifert M; Schneider J; Ojak A; Zang KD; Mehraein Y
J Rheumatol; 2006 Jan; 33(1):16-23. PubMed ID: 16395745
[TBL] [Abstract][Full Text] [Related]
7. Characterization of human endogenous retroviral elements in the blood of HIV-1-infected individuals.
Contreras-Galindo R; Kaplan MH; Contreras-Galindo AC; Gonzalez-Hernandez MJ; Ferlenghi I; Giusti F; Lorenzo E; Gitlin SD; Dosik MH; Yamamura Y; Markovitz DM
J Virol; 2012 Jan; 86(1):262-76. PubMed ID: 22031938
[TBL] [Abstract][Full Text] [Related]
8. Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection.
Michaud HA; de Mulder M; SenGupta D; Deeks SG; Martin JN; Pilcher CD; Hecht FM; Sacha JB; Nixon DF
Retrovirology; 2014 Jan; 11():10. PubMed ID: 24472118
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 infection leads to increased transcription of human endogenous retrovirus HERV-K (HML-2) proviruses in vivo but not to increased virion production.
Bhardwaj N; Maldarelli F; Mellors J; Coffin JM
J Virol; 2014 Oct; 88(19):11108-20. PubMed ID: 25056891
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional profiling of human endogenous retrovirus group HERV-K(HML-2) loci in melanoma.
Schmitt K; Reichrath J; Roesch A; Meese E; Mayer J
Genome Biol Evol; 2013; 5(2):307-28. PubMed ID: 23338945
[TBL] [Abstract][Full Text] [Related]
11. Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project.
Flockerzi A; Ruggieri A; Frank O; Sauter M; Maldener E; Kopper B; Wullich B; Seifarth W; Müller-Lantzsch N; Leib-Mösch C; Meese E; Mayer J
BMC Genomics; 2008 Jul; 9():354. PubMed ID: 18664271
[TBL] [Abstract][Full Text] [Related]
12. Human endogenous retrovirus HERV-K(HML-2) env expression is not associated with markers of immunosenescence.
Marttila S; Nevalainen T; Jylhävä J; Kananen L; Jylhä M; Hervonen A; Hurme M
Exp Gerontol; 2017 Oct; 97():60-63. PubMed ID: 28774724
[TBL] [Abstract][Full Text] [Related]
13. HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates.
Jones RB; Garrison KE; Mujib S; Mihajlovic V; Aidarus N; Hunter DV; Martin E; John VM; Zhan W; Faruk NF; Gyenes G; Sheppard NC; Priumboom-Brees IM; Goodwin DA; Chen L; Rieger M; Muscat-King S; Loudon PT; Stanley C; Holditch SJ; Wong JC; Clayton K; Duan E; Song H; Xu Y; SenGupta D; Tandon R; Sacha JB; Brockman MA; Benko E; Kovacs C; Nixon DF; Ostrowski MA
J Clin Invest; 2012 Dec; 122(12):4473-89. PubMed ID: 23143309
[TBL] [Abstract][Full Text] [Related]
14. Human endogenous retrovirus K (HML-2) RNA and protein expression is a marker for human embryonic and induced pluripotent stem cells.
Fuchs NV; Loewer S; Daley GQ; Izsvák Z; Löwer J; Löwer R
Retrovirology; 2013 Oct; 10():115. PubMed ID: 24156636
[TBL] [Abstract][Full Text] [Related]
15. Human endogenous retrovirus HERV-K(HML-2) RNA causes neurodegeneration through Toll-like receptors.
Dembny P; Newman AG; Singh M; Hinz M; Szczepek M; Krüger C; Adalbert R; Dzaye O; Trimbuch T; Wallach T; Kleinau G; Derkow K; Richard BC; Schipke C; Scheidereit C; Stachelscheid H; Golenbock D; Peters O; Coleman M; Heppner FL; Scheerer P; Tarabykin V; Ruprecht K; Izsvák Z; Mayer J; Lehnardt S
JCI Insight; 2020 Apr; 5(7):. PubMed ID: 32271161
[TBL] [Abstract][Full Text] [Related]
16. CpG methylation directly regulates transcriptional activity of the human endogenous retrovirus family HERV-K(HML-2).
Lavie L; Kitova M; Maldener E; Meese E; Mayer J
J Virol; 2005 Jan; 79(2):876-83. PubMed ID: 15613316
[TBL] [Abstract][Full Text] [Related]
17. Human endogenous retrovirus expression profiles in samples from brains of patients with schizophrenia and bipolar disorders.
Frank O; Giehl M; Zheng C; Hehlmann R; Leib-Mösch C; Seifarth W
J Virol; 2005 Sep; 79(17):10890-901. PubMed ID: 16103141
[TBL] [Abstract][Full Text] [Related]
18. The human endogenous retrovirus K(HML-2) has a broad envelope-mediated cellular tropism and is prone to inhibition at a post-entry, pre-integration step.
Kramer P; Lausch V; Volkwein A; Hanke K; Hohn O; Bannert N
Virology; 2016 Jan; 487():121-8. PubMed ID: 26517399
[TBL] [Abstract][Full Text] [Related]
19. A Comprehensive Analysis of Human Endogenous Retroviruses HERV-K (HML.2) from Teratocarcinoma Cell Lines and Detection of Viral Cargo in Microvesicles.
Morozov VA; Morozov AV
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830279
[TBL] [Abstract][Full Text] [Related]
20. Viral eradication reduces both liver stiffness and steatosis in patients with chronic hepatitis C virus infection who received direct-acting anti-viral therapy.
Tada T; Kumada T; Toyoda H; Sone Y; Takeshima K; Ogawa S; Goto T; Wakahata A; Nakashima M; Nakamuta M; Tanaka J
Aliment Pharmacol Ther; 2018 Apr; 47(7):1012-1022. PubMed ID: 29424449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
